Scientists say they have identified a long-sought explanation for how a common gut bacterium may help drive colorectal cancer. The study, published in Nature, centers on Bacteroides fragilis, a microbe found in the human gut that has been linked to colon tumors for years.
The new research helps clarify how this bacterium can promote cancer development, giving researchers a clearer picture of the biological pathway behind the risk. That matters because colorectal cancer is one of the most common cancers worldwide, and scientists have been trying to understand how the gut microbiome may influence who develops the disease.
By narrowing down the mechanism involved, the findings could point to new ways to prevent or treat colorectal cancer. A gastroenterologist told Newsweek the work may help guide future strategies, including approaches aimed at reducing harmful bacterial effects in the gut or targeting the process that leads to tumor growth.
The study also adds to growing evidence that certain gut microbes do more than coexist with disease and may actively shape cancer risk. While more research will be needed before the findings change patient care, the results offer an important step toward turning microbiome science into practical tools for colorectal cancer prevention and treatment.
